The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | 23.4x | 20.1x | Near average | |
Growth | 44 | 9.1% | 5.6% | Near average | |
Quality | 66 | 16.8% | 7.6% | Near average | |
Safety | 39 | 4.0x | 0.4x | Near average | |
Capital Return | 83 | 5.01% | 2.19% | Above average | |
Momentum | 45 | — | — | Near average | |
Sentiment | 52 | — | — | Near average |
Amgen Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Amgen Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The average price target for AMGN has shown notable stability at 352 dollars over the past week, recording a slight increase of 0.45% compared to last month's levels. This stability reflects a state of anticipation among the 13 analysts covering the stock, as the current price (337.42 dollars) trades close to the average target, narrowing the expected upside margin in the short term.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.